• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Watson Pharma launches generic of J&J's Concerta

      Posted Atforbes.com

      Watson Pharmaceuticals Inc. said Monday it has started selling an authorized generic version of Johnson & Johnson's attention deficit hyperactivity disorder drug Concerta.

      Watson said sales of Concerta, or methylphenidate, totaled $1.5 billion in the year that ended Feb. 28.

      Concerta is to treat ADHD in children ages 6 to 17, and adults 18 to 65. It's an extended-release drug with the same active ingredient as Ritalin.

      Under an agreement the companies announced in November, Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceutical unit is making and supplying the drug, and it will receive a share of the revenue from sales. Watson will market and distribute the generic.

      The agreement lasts until the end of 2014. Watson can launch its own generic version when the deal ends.

      Watson is based in Parsippany, N.J., and Johnson & Johnson in New Brunswick, N.J. Shares of Watson rose $1.07 to $63.09 in afternoon trading. Johnson & Johnson's stock rose 42 cents to $66.14.

      May 04, 2011


      Share this Article!

    Back to top^